NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (TOI)

Compare
0.4525 +0.0025 (+0.54%)
As of 1:18 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Richard Alan Barasch Chairman of the Board -- -- 1954
Dr. Daniel Virnich FACHE, M.D., MBA Chief Executive Officer 614.62k -- 1979
Mr. Mihir Arunkumar Shah CPA Chief Financial Officer 505.13k -- 1978
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. Chief Medical Officer 535.36k -- 1972
Mr. Jeremy N. Castle M.B.A. Chief Operations Officer -- -- 1984
Mr. Mark Hueppelsheuser Esq. General Counsel -- -- --
Ms. Laura Szitar Chief People Officer -- -- --
Mr. Jordan McInerney Chief Development Officer -- -- --

The Oncology Institute, Inc.

18000 Studebaker Road
Suite 800
Cerritos, CA 90703
United States
(562) 735-3226 https://theoncologyinstitute.com
Sector: 
Healthcare
Full Time Employees: 
800

Description

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Corporate Governance

The Oncology Institute, Inc.’s ISS Governance QualityScore as of June 1, 2024 is 9. The pillar scores are Audit: 4; Board: 9; Shareholder Rights: 6; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 6, 2024 at 10:59 AM UTC - August 12, 2024 at 12:00 PM UTC

The Oncology Institute, Inc. Earnings Date

Recent Events

June 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 6, 2024 at 1:00 PM UTC

at Jefferies Heathcare Conference

May 22, 2024 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

May 14, 2024 at 9:00 PM UTC

Q1 2024 Earnings Call

May 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 2, 2024 at 12:00 AM UTC

DEFA14A: Proxy Statements

April 26, 2024 at 12:00 AM UTC

ARS: Annual Report to Shareholders

April 22, 2024 at 12:00 AM UTC

PRE 14A: Proxy Statements

April 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 28, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers